Close

Form PRE 14A Cantor Fitzgerald Income For: Dec 05 Sep 22, 2023 02:41PM
Form 424B3 CANTOR FITZGERALD INFRAS Sep 22, 2023 10:01AM
Cantor Fitzgerald Starts Alector Inc. (ALEC) at Overweight, 'Leading Immuno-Neuro Platform to Drive Value from Two, Not One, Pipeline Assets' Sep 22, 2023 06:32AM
Cantor Fitzgerald Starts Solid Biosciences (SLDB) at Overweight Sep 22, 2023 06:32AM
Gorilla Technology Group (GRRR) Announce $25M Convertible Stock Offering Sep 20, 2023 08:01AM
View Older Stories

Sep 19, 2023 05:02PM Form 424B3 Cantor Fitzgerald Income
Sep 19, 2023 06:13AM Cantor Fitzgerald Starts Akero Therapeutics (AKRO) at Overweight, 'Positive on Upcoming F4 NASH Readout'
Sep 12, 2023 07:37AM Cantor on Lyra Therapeutics (LYRA):'Better-Than-Expected BEACON Results Expand Opportunity for LYRA's CRS Platform'
Sep 12, 2023 06:39AM Acelyrin (SLRN) crashes 60% as lead product misses in study; Seen as a 'big positive' for MoonLake (MLTX)
Sep 12, 2023 04:43AM CymaBay Therapeutics (CBAY) Prices Upsized $225M Share and Warrant Offering at $17.13/sh
Sep 11, 2023 06:00AM CymaBay Therapeutics (CBAY) Announces Proposed $150M Share and Warrant Offering
Sep 8, 2023 06:07AM Cantor Fitzgerald Starts Atossa Genetics (ATOS) at Overweight, 'Changing the Treatment Paradigm in Breast Cancer'
Sep 6, 2023 05:01PM Form 8-K Cantor Fitzgerald Income For: Sep 06
Aug 31, 2023 04:32PM Intuitive Machines (LUNR) Announces $20M Equity Investment
Aug 29, 2023 08:44AM Form NPORT-P CANTOR FITZGERALD SUSTAI For: Jun 30
Aug 28, 2023 06:34AM Cantor Starts NextGen Healthcare Inc (NXGN) at Overweight, 'attractive investment profile that is not fully reflected'
Aug 25, 2023 04:42AM Cantor Fitzgerald Upgrades Ardelyx, Inc (ARDX) to Overweight
Aug 24, 2023 06:21PM Connect Biopharma to Participate in Upcoming September Investor Conferences
Aug 24, 2023 08:00AM Alpha Tau Medical to Participate in September Investor Conferences
Aug 24, 2023 05:55AM Cybin Inc (CYBN) Renews $35M At-The-Market Equity Program
Aug 23, 2023 09:37PM Cybin Announces Renewed At-The-Market Equity Program of up to US$35 Million
Aug 23, 2023 10:54AM Form N-PX CANTOR FITZGERALD SUSTAI For: Jun 30
Aug 23, 2023 09:00AM Arcus Biosciences to Participate in Multiple Upcoming Investor Conferences
Aug 22, 2023 09:00AM Borqs Technologies Received Extension from CFIUS for HHE Divestment, and Will Consider Share Buyback and/or Pay a Special Dividend
Aug 18, 2023 03:11PM Form N-23C3A CANTOR FITZGERALD SUSTAI For: Aug 18
Aug 18, 2023 07:00AM Augmedix Announces Participation in Upcoming Investor Conferences in September 2023
Aug 17, 2023 01:25PM BioMedNewsBreaks – RVL Pharmaceuticals plc (NASDAQ: RVLP) Spotlighted in New Cantor Fitzgerald Research Brief
Aug 17, 2023 08:30AM Arcturus Therapeutics to Attend Upcoming Investor Conferences
Aug 16, 2023 04:50PM Orchid Island Capital Announces August 2023 Monthly Dividend and July 31, 2023 RMBS Portfolio Characteristics
Aug 15, 2023 05:01PM Form 424B3 Cantor Fitzgerald Income
Aug 15, 2023 06:33AM Cantor Fitzgerald Starts Computer Programs and Systems (CPSI) at Overweight
Aug 14, 2023 04:07PM Alaunos Therapeutics (TCRT) to wind down its TCR-T Library Phase 1/2 trial and prioritize the hunTR platform
Aug 14, 2023 04:05PM Alaunos Therapeutics Announces Second Quarter 2023 Financial Results, Interim Clinical Data and Exploration of Strategic Alternatives
Aug 14, 2023 03:45PM Form 13F-NT CANTOR FITZGERALD & CO. For: Jun 30
Aug 14, 2023 03:45PM Form 13F-NT CANTOR FITZGERALD INVEST For: Jun 30
Aug 14, 2023 03:44PM Form 13F-NT Cantor Fitzgerald Europe For: Jun 30
Aug 14, 2023 03:44PM Form 13F-NT CANTOR FITZGERALD SECURI For: Jun 30
Aug 14, 2023 03:42PM Form 13F-HR CANTOR FITZGERALD, L. For: Jun 30
Aug 14, 2023 08:16AM The Metals Company (TMC) Announces $27 Million Registered Direct Offering at $2.00 Per Share Plus Class A Warrants
Aug 14, 2023 08:15AM The Metals Company Announces ~US$27 Million Registered Direct Offering at $2.00 Per Share Plus Class A Warrants
Aug 11, 2023 04:20PM Form 10-Q Cantor Fitzgerald Income For: Jun 30
Aug 10, 2023 04:05PM Trevi Therapeutics Announces Second Quarter 2023 Financial Results and Provides Business Update
Aug 10, 2023 04:05PM Phunware Reports Second Quarter 2023 Financial Results
Aug 10, 2023 02:00PM Guanajuato Silver Closes C$8,010,000 "Bought Deal" Financing
Aug 10, 2023 07:00AM MoonLake Immunotherapeutics Reports Second Quarter 2023 Financial Results and Provides a Business Update
Aug 10, 2023 06:45AM Susan Munson and Andrew Davidoff Join Academy Securities as Managing Directors, Rates Liquidity
Aug 10, 2023 05:57AM Cantor Fitzgerald Starts Zai Lab (ZLAB) at Overweight
Aug 10, 2023 05:26AM Addimmune to Go Public via Merger with 10X Capital Venture Acquisition Corp. III (VCXB)
Aug 9, 2023 09:07PM Correction: Addimmune, a Clinical Stage HIV-Focused Gene Therapy Company, to go Public Through Business Combination With 10X Capital Venture Acquisition Corp. III
Aug 9, 2023 09:07PM Correction: Addimmune, a Clinical Stage HIV-Focused Gene Therapy Company, to go Public Through Business Combination With 10X Capital Venture Acquisition Corp. III
Aug 9, 2023 07:02PM Addimmune, a Clinical Stage Hiv-Focused Gene Therapy Company, to go Public Through Business Combination With 10x Capital Venture Acquisition Corp. III
Aug 9, 2023 07:02PM Addimmune, a Clinical Stage Hiv-Focused Gene Therapy Company, to go Public Through Business Combination With 10x Capital Venture Acquisition Corp. III
Aug 9, 2023 04:06PM Form S-11 Cantor Fitzgerald Income
Aug 7, 2023 07:04AM Tabula Rasa HealthCare (TRHC) to be Acquired by Nautic Partners for $10.50 Per Share, $570 Million
View Older Stories